Download PDF
Thromb Haemost 1997; 78(01): 537-542
DOI: 10.1055/s-0038-1657584
Transgenic production of hemostasis proteins
Schattauer GmbH Stuttgart

Current Progress in the Production of Recombinant Human Fibrinogen in the Milk of Transgenic Animals

Stephen P Butler
1   Department of Dairy Science, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA
,
Kevin van Cott
2   Department of Chemical Engineering, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA
,
Anuradha Subrumanian
1   Department of Dairy Science, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA
,
Francis C Gwazduaskas
1   Department of Dairy Science, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA
,
William H Velander
2   Department of Chemical Engineering, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Alving BM, Weinstein MJ, Finlayson JS, Menitove JE, Frantantoni JC. Fibrin sealant: summary of a conference on characteristics and clinical uses. Transfusion 1995; 35: 783-790
    CrossrefPubMedGoogle Scholar
  • 2 Greco F, de Palma L, Spagnolo N, Rossi A, Specchia N, Gigante A. Fibrin-antibiotic mixtures: an in vitro study assessing the possibility of using a biologic carrier for local drug delivery. J Biomed Mat Res 1991; 25: 39-51
    CrossrefPubMedGoogle Scholar
  • 3 MacPhee M, Campagna A, Kidd R, Best A, Drohan WN. Fibrin sealant as a delivery vehicle for sustained and controlled release of chemotherapy agents. In: Surgical Adhesives and Sealants: Current Technology and Applications. Sierra D, and Saltz R. eds Technomic Publishing Co; Lancaster, PA: 1996
    Google Scholar
  • 4 MacPhee M, Nunez H, Hennings R, Campagna A, Grummon G, Harding S, Drohan W. Sustained release in vitro and in vivo of antibiotics from fibrin sealant. In: Surgical Adhesives and Sealants: Current Technology and Applications. Sierra D, and Saltz R. eds. Technomic Publishing Co; Lancaster, PA: 1996
    Google Scholar
  • 5 Lasa C, Hollinger J, Drohan W, MacPhee M. Bone induction by demineralized bone powder and partially purified osteogenin using a fibrin-sealant carrier. In: Surgical Adhesives and Sealants: Current Technology and Applications. Sierra D, and Saltz R. eds. Technomic Publishing Co; Lancaster, PA: 1996
    Google Scholar
  • 6 Paleyanda R, Young J, Velander W. et al. The expression of therapeutic proteins in transgenic animals. In Hoyer LW, and Drohan WN. eds. Recombinant Technology in Hemostasis and Thrombosis . New York: Plenum Press; 1991: 197-209
    CrossrefGoogle Scholar
  • 7 Haenlein GFW. Dairy Goat industry of the United States. J dairy Sci 1981; 64: 1288-1304
    CrossrefPubMedGoogle Scholar
  • 8 Van Cott KE, Lubon H, Russell CG, Butler SP, Gwazdauskas FC, Knight J, Drohan WN, Velander WH. Phenotypic and genotypic stability of multiple lines of transgenic pigs expressing recombinant human protein C. Transgenic Res 1997; 06: 01-10
    CrossrefPubMedGoogle Scholar
  • 9 Velander WH, Johnson JL, Page RL. et al. High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C. Proc Natl Acad Sci USA 1992; 89: 12003-12007
    CrossrefPubMedGoogle Scholar
  • 10 Punkard D, Cottingham I, Garner I, Bruce S, Dairymple M, Lasser G, Bishop B, Foster D. High-level expression of recombinant human fibrinogen in the milk of transgenic mice. Bio/Technol 1996; 14: 867-871
    PubMedGoogle Scholar
  • 11 Cottingham I, McKee C, Temperley S, Gamer I, Prunkard D, Lasser G, Bishop P, Foster D. Human fibrinogen from the milk of transgenic sheep. In: Tissue Sealants: Current Practice, Future Uses. Cambridge Institute; Newton Upper Falls, MA: 30.04.1996. (abstract)
    Google Scholar
  • 12 Lubon H, Paleyanda RK, Velander WH. et al. Blood proteins from transgenic animal bioreactor s. Transfusion Med Rev 1996; 10: 131-143
    CrossrefPubMedGoogle Scholar
  • 13 Van Cott KE, Williams BL, Velander WH. et al. Affinity purification of biologically active and inactive forms of recombinant human protein C produced in porcine mammary gland. Journal of Molecular Recognition 1997; 09: 407-414
    PubMedGoogle Scholar
  • 14 Paleyanda RK, Zhang D, Hennighausen L, McKnight RA, Lubon H. Regulation of human protein C gene expression by the mouse WAP promoter. Transgenic Res 1994; 03: 335-343
    CrossrefPubMedGoogle Scholar
  • 15 McKnight RA, Spencer M, Dittmer J, Brady JN, Wall RJ, Henninghausen L. An Ets site in the whey acidic protein gene promoter mediates transcriptional activation in the mammary gland of pregnant mice but is dispensable during lactation. Mol. Endocrinol 1995; 09: 717-724
    PubMedGoogle Scholar
  • 16 Yu S, Sher B, Kudryk B, Redman CM. Fibrinogen precursors, order of assembly of fibrinogen chains. J Bio Chem 1984; 259: 10574-10581
    PubMedGoogle Scholar
  • 17 Hartwig R, and Danishefsky KJ. Studies on the assembly and secretion of fibrinogen. J Biol Chem 1991; 266: 6578-6585
    PubMedGoogle Scholar
  • 18 Roy SN, Procyk R, Kudryk BJ, Redman CM. Assembly and secretion of recombinant human fibrinogen. J Biol Chem 1991; 266: 4758-4763
    PubMedGoogle Scholar
  • 19 Huang S, Mulvihill ER, Fairell DH, Chung DW, Davie EW. Biosysthesis of human fibrinogen. J Bio Chem 1993; 268: 8919-8926
    PubMedGoogle Scholar
  • 20 Danishefsky K, Hartwig R, Banerjee D, Redman C. Intracellular fate of fibrinogen Bb chain expressed in COS cells. Biochim BiophyActa, 1990; 1048: 201-208
    PubMedGoogle Scholar
  • 21 Lord ST, Strickland E, Jayjock E. Strategy for recombinant multichain protein synthesis: fibrinogen Bb-chain variants as thrombin substrates. Biochem 1996; 35: 2342-2348
    CrossrefPubMedGoogle Scholar
  • 22 Yu S, Sher B, Kudryk B, Redman CM. Intracellular assembly of human fibrinogen. J. Biol Chem 1983; 258: 13407-13410
    PubMedGoogle Scholar
  • 23 Lee TK, Drohan WN, Lubon H. Proteolytic processing of human protein C in swine mammary gland. J Biochem 1995; 118: 81-87
    CrossrefPubMedGoogle Scholar
  • 24 Roy SN, Kudryk B, Redman CM. Secretion of biologically active recombinant fibrinogen by yeast. J Biol Chem 1995; 270: 23761-23767
    CrossrefPubMedGoogle Scholar
  • 25 Morcol T, Akers RM, Johnson JL. et al. The porcine mammary gland as a bioreactor for complex proteins. Annal NY Acad Sci 1994; 721: 218-233
    CrossrefPubMedGoogle Scholar